US resumes J&J vaccinations despite rare clot risk

US resumes J&J vaccinations despite rare clot risk

USATODAY.com

Published

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. (April 23)
 

Full Article